down arrow

Praveg

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: INE722B01019
  • NSEID:
  • BSEID: 531637
INR
575.10
18.2 (3.27%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 41.36 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Praveg Ltd stock-summary
stock-summary
Praveg Ltd
Small Cap
Miscellaneous
Praveg Limited was formerly incorporated as 'Sword & Shield Pharma Limited' on March 23, 1992 with the Registrar of Companies, Gujarat State. The Company obtained Certificate of Commencement on March 7, 1995. Thereafter, the name of the Company changed from 'Sword & Shield Pharma Limited' to 'Praveg Communications (India) Limited' dated December 2, 2020. Further, the Company changed the name from 'Praveg Communications (India) Limited' to 'Praveg Limited' on November 28, 2022.
Company Coordinates stock-summary
Company Details
214 Athena Avenue S G Highway, Gota Ahmedabad Gujarat : 382481
stock-summary
Tel: 91-79-27496737
stock-summary
cs@praveg.com
Registrar Details
Sword & Shield Pharma Ltd., 311, Rajkamal Plaza-b, Nr. Samruddhi Bldg,, Opp. High Court, Income Tax,, Ahmedabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 25.83 Cr
Number of Shares
2.58 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
17-May-2024
2.58
25.83
1293024
10
Preferential basis
07-Feb-2024
2.45
24.50
1490000
10
Preferential basis
30-Jan-2024
2.3
23.01
95600
10
Conversion of Warrants
25-Jan-2024
2.29
22.92
49212
10
Conversion of Warrants
16-Jan-2024
2.29
22.87
28025
10
Conversion of Warrants
22-Nov-2023
2.28
22.84
200000
10
Conversion of Warrants
14-Aug-2023
2.26
22.64
545533
10
Preferential basis
25-Jul-2023
2.21
22.09
71975
10
Conversion of Warrants
24-Jun-2023
2.2
22.02
500000
10
Conversion of Warrants
21-Jun-2023
2.15
21.52
385000
10
Conversion of Warrants
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (2.68%)

FIIs

Held by 19 FIIs (10.3%)

Promoter with highest holding

Vishnukumar Vitthaldas Patel (21.11%)

Highest Public shareholder

Goldman Sachs Fund (2.15%)

Individual Investors Holdings

28.68%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Mukesh Chaudhary
Company Secretary
2.25 lacs
Paraskumar Maneklal Patel
Managing Director
24.0 lacs
Sunita Paras Patel
Whole-time Director
8.4 lacs
Vishnukumar Vitthaldas Patel
Chairman (Non-Executive)
0
Keyoor Madhusudan Bakshi
Addtnl Independent Director
0
Ajit Panda
Addtnl Independent Director
0
Jaladhi Shah
Addtnl Independent Director
0
Rajendrakumar Patel
Addtnl Independent Director
0
Mukesh Chaudhary
Company Sec. & Compli. Officer
0
Prolina Barada
Additional Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Commission for Pharma Products
0.03
100.00%
 
100
Commission for Pharma Products
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
54 Cr
(Quarterly Results - Dec 2024)
Net Profit:
9 Cr
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

INR 1,503 Cr (Small Cap)

stock-summary
P/E

113.00

stock-summary
Industry P/E

28

stock-summary
Dividend Yield

0.18%

stock-summary
Debt Equity

-0.10

stock-summary
Return on Equity

2.71%

stock-summary
Price to Book

3.32